-
Nov 18, 2023
Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine
BMC Infectious Diseases
view more -
Nov 16, 2023
How Evolution Impacts the Environment
KINGSTON, RI — The story of the peppered moths is a textbook evolutionary tale.
view more -
Nov 14, 2023
Inspired Workspaces, Safe Environments: Lab Designs for All Biosafety Levels
Are inspiring and magnetic research facilities incompatible with safe and
view more -
Nov 12, 2023
To Increase Women in STEM Jobs, Increase Female Leadership
Despite efforts to diversify the fields of science, technology, engineering, and
view more -
Nov 10, 2023
InflaRx plans to launch Covid antibody with five
A day after winning emergency use authorization for its Covid-19
view more -
Nov 08, 2023
Universal redirection of CAR T cells against solid tumours via membrane
Nature Biomedical Engineering
view more -
Nov 06, 2023
New Data Show Genentech’s Subcutaneously Administered Crovalimab Achieved Disease Control and Was Well
– The COMMODORE 2 study demonstrated that subcutaneous crovalimab every four
view more -
Nov 04, 2023
A method for parallel microscale protein labeling and precise control over the average degree of labeling (aDoL)
Scientific Reports volume 13,
view more -
Nov 02, 2023
To Increase Women in STEM Jobs, Increase Female Leadership
Despite efforts to diversify the fields of science, technology, engineering, and
view more -
Oct 31, 2023
HER2
Dr. Cameron McAlpine To commemorate World Multiple Sclerosis (MS) Day, we speak
view more -
Oct 29, 2023
Statement on the antigen composition of COVID
The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC)
view more -
Oct 27, 2023
Global CD137 Antibodies Clinical Trials Market Analysis Report 2023: First Commercially Available CD137 Antibody in Next 6 to 7 Years
DUBLIN, June 7, 2023 /PRNewswire/ -- The "Global CD137 Antibodies Clinical
view more
SEND YOUR INQUIRY
SUBMIT